ML18212A055
| ML18212A055 | |
| Person / Time | |
|---|---|
| Site: | 03018133 |
| Issue date: | 07/31/2018 |
| From: | Frazier C F NRC/RGN-III |
| To: | DLP Marquette General Hosp, UP Health System Marquette |
| References | |
| 608626 | |
| Download: ML18212A055 (4) | |
Text
NRC FORM 374 U.S. NUCLEAR REGULATORY COMMISSION MATERIALS LICENSE PAGE 1 OF 4 PAGES Amendment No. 79 Pursuant to the Atomic Energy Act of 1954, as amended, the Energy Reorganization Act of 1974 (Public Law 93-438), and Title 10, Code of Federal Regulations, Chapter I, Parts 30, 31, 32, 33, 34, 35, 36, 37, 39, 40, 70 and 71, and in reliance on statements and representations heretofore made by the licensee, a license is hereby issued authorizing the licensee to receive, acquire, possess, and transfer byproduct, source, and special nuclear material designated below; to use such material for the purpose(s) and at the place(s) designated below; to deliver or transfer such material to persons authorized to receive it in accordance with the regulations of the applicable Part(s). This license shall be deemed to contain the conditions specified in Section 183 of the Atomic Energy Act of 1954, as amended, and is subject to all applicable rules, regulations, and orders of the Nuclear Regulatory Commission now or hereafter in effect and to any conditions specified below. Licensee In accordance with letter dated 4. Expiration Date: July 31, 2024 1. OLP Marquette General Hospital, LLC d/b/a UP Health System -Marquette April t-------------ii-_.,.,....----1
- 5. Docket No.: 030-18133 Reference No.: 2. 580 W College Ave. Marquette, Ml 49855 6. Byproduct, source, 7. Chemical afMklr physical fO!l!lir&
'** 8: .,, Max;limlll(lount that licensee 9. Authorized use and/or special nuclear material A. Any byproduct material A. Any A. For use in uptake, dilution and permitted by 10 CFR excretion studies permitted by 10 CFR 35.100 35.100. B. Any byproduct material B. Any B. For use in imaging and localization permitted by 10 CF.R studies permitted by 10 CFR 35.200. 35.200 C. Any byproduct material C. Any C. 9curi~tal~
C. For any use permitted by 10 CFR permitted by 10 CFR 35.300. 35.300 D. lridium-192 permitted by D. Sealed Sources (Best Medical D. 600 millicuries total D. For any manual brachytherapy 10 CFR 35.400 International, Inc., Model 81-01) procedure permitted by 10 CFR 35.400. E. Yttrium-90 permitted by E. Microspheres (Sirtex Wilmington E. 1.08 curies total E. For medical use, as permitted by 10 10 CFR 35.1000 LLC, Sirtex Medical Limited, or CFR 35.1000, in a Sirtex Medical ANSTO Radiopharmaceuticals Limited brachytherapy afterloader and Industrials, Model delivery system. SIR-Spheres microspheres)
NRC FORM 374A U.S. NUCLEAR REGULATORY COMMISSION MATERIALS LICENSE SUPPLEMENTARY SHEET License Number 21-05432-04 Amendment No. 79 6. Byproduct, source, and/or special nuclear material 7. Chemical and/or physical form Docket or Reference Number 030-18133
- a. Maximum amount thatlicensee may possess at any one time e111~ t,tlis license 9. Authorized use PAGE 2 OF 4 PAGES F. Uranium-depleted in Uranium-235 F. Metal 9WkW,ms total 4 ., F. In solid, metal form, for use as shielding in generators. . v, 10. A. Licensed material may be used or slifd at thi , B. Licensed material may also be use;.,w stored at 11. The Radiation Safety Officer (RSO) for\tnts licen~~ is 12. Licensed material shall only be used by, MFWnd vr* CONDITIONS O Wes~1 agnetic Street, Marquette, Michigan.
d at 580 ~,st College Avenue, Marquette, Michigan.
! * \)) /'; -,~;~:") :**.. . ', ,'. A. Individuals permitted to work as author~~sers in adco~t1,i~~
10'.¢FR 35. 10 CFR 35.14. B. The following individuals are authorized users f6r tt\~trnaterial and mediqaJuse
<' "<,,]<< ,'\ a-Authorized User(M.D.,D.O.,etc.)
Material anctJOse ~-,, \j James R. Baer, M.D. 10 CFR 35.300; 10 CFR 35.400 Gary M. Friesen, M.D. Nelson E. Gencheff, D.O. Christopher J. Mehall, M.D. Michael Ouimette, M.D. John Michael Pap, M.D. 10 CFR 35.200 10 CFR 35.200 10 CFR 35.100, 10 CFR 35.200, 10 CFR 35.300; 10 CFR 35.1000 (limited to yttrium-90 SIR-spheres in a Sirtex Medical Limited brachytherapy afterloader delivery system) 10 CFR 35.100, 10 CFR 35.200, 10 CFR 35.300; 10 CFR 35.1000 (limited to yttrium-90 SIR-spheres in a Sirtex Medical Limited brachytherapy afterloader delivery system) 10 CFR 35.100, 10 CFR 35.200 NRC FORM 374A MATERIALS LICENSE SUPPLEMENTARY SHEET U.S. NUCLEAR REGULATORY COMMISSION License Number 21-05432-04 Amendment No. 79 Material and Use Docket or Reference Number 030-18133 PAGE 3 OF 4 PAGES Authorized User(M.D.,D.O.,etc.}
John Phillip Cox, D.O. 10 CFR 35.100,10 C~~5.200; 10 CFR 35.300 (limited to oral administration of sodium iodide 1-13.1 ~cf;\mtitl>@ty5curies or less) 13. Except as specifically provided otherwise in t1J},1teense, the licensee shall con;j ~.I?!ogram in accordance with the statements, representations, and procedures contained~~
documents, including any enclosur~listed below. This license condition applies only to those procedures that are required to be sul,,i,itted in accordance with the regulations.
~itionally, this license condition does not limit the license_e*~
ability to m~ke changes to the 1'<t,iatio"I
- ction program as ~ro~. ,?fin 1~FR_35.26._
The U.S. Nuc_lea~ Regulatory Comm1ss1on's regulations shall_g~vern u11Uss the :" . ts, r:~~e~enta~n proce~s in the licensee's apphcat1on and correspondence are more restrictive th~he regulatr ' ,~.,.*' * * * ' A. Letter dated April 11, 2005 (ML051 CIP330) B. Letter dated May 25, 2005 (ML052t,8{)293)
C. Letter dated August 12, 2009 (MLO§u602 D. Letter dated February 23, 2010 (ML 1f)8541 E. Letter dated February 7, 2014 (ML 14 F. Letter dated May 13, 2014 (ML 14140A 4! G. Letter dated June 19, 2014 (ML 14182A33 H. Letter dated July 28, 2014 (ML 14223A605)
I. Letter dated December 1, 2014 (ML 14343A572)
J. Letter c;iated January 16, 2015 (ML 15064A020)
K. Letter dated July 8, 2015 (ML 15191A375)
NRC FORM 374A U.S. NUCLEAR REGULATORY COMMISSION PAGE 4 OF 4 PAGES MATERIALS LICENSE SUPPLEMENTARY SHEET License Number 21-05432-04 Amendment No. 79 L. Letter dated May 11, 2017 (ML 17143A164)
M. Letter dated June 13, 2017 (ML 17164A067)
- 0. Letter dated June 22, 2017 (ML 17173A814)
P. Letter dated August 8, 2017 (ML 17236A Date: JUL 3*l101B Docket or Reference Number 030-18133 By* */-------------+'---------¥-----------
Cassandra F. Frazier Region 3